Answers are grounded in this paper and cite their sources.
Subcutaneous implantable cardioverter-defibrillators (S-ICDs) are a safe and effective device for prevention of sudden cardiac death.1 Thus, the S-ICD was developed as an alternative therapy to a transvenous ICD (TV-ICD) in patients without an indication of bradycardia or antitachycardia pacing. Compared to the TV-ICD, the defibrillation threshold of the S-ICD is thought to be higher because both the lead and pulse generator are located outside the thorax. In actuality, the maximum delivery energy is set at a value of 80 J.
No takes yet. Share an insight, caveat, or question.
Sonoda et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: